D

Denali Therapeutics
D

DNLI

15.210
USD
-0.15
(-0.98%)
مفتوح الان
حجم التداول
8,032
الربح لكل سهم
-3
العائد الربحي
-
P/E
-5
حجم السوق
2,225,350,871
أصول ذات صلة الأخبار المقالات

العنوان: Denali Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brainpenetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.